ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ESTHER KRUG M.D.

Endocrinology, Diabetes Metabolism

7,297

$1.24M

319
291 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 47%

$170
Average prescription price

Avg: $159

IRENE FELDMAN M.D.

Endocrinology, Diabetes Metabolism

5,870

$529K

273
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 47%

$90
Average prescription price

Avg: $159

MAHETEME BAYEH MD

Endocrinology, Diabetes Metabolism

5,589

$397K

171
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 47%

$71
Average prescription price

Avg: $159

ANN MORRILL MD

Endocrinology, Diabetes Metabolism

4,790

$475K

314
226 are 65+

24%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 47%

$99
Average prescription price

Avg: $159

BRUCE SINDLER M.D.

Endocrinology, Diabetes Metabolism

4,617

$511K

304
240 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 47%

$111
Average prescription price

Avg: $159

JACK SNITZER DO

Endocrinology, Diabetes Metabolism

3,950

$763K

504
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 47%

$193
Average prescription price

Avg: $159

MUHAMMAD SMITH MD,FACE

Endocrinology, Diabetes Metabolism

3,450

$536K

469
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 47%

$155
Average prescription price

Avg: $159

MAHMOOD MOHAMADI M.D.

Endocrinology, Diabetes Metabolism

3,298

$398K

271
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 47%

$121
Average prescription price

Avg: $159

ROY PHILLIPS MD

Endocrinology, Diabetes Metabolism

3,287

$695K

336
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 47%

$212
Average prescription price

Avg: $159

STEPHEN SMITH MD

Endocrinology, Diabetes Metabolism

3,285

$232K

235
133 are 65+

17%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 47%

$71
Average prescription price

Avg: $159

HERBERT JUARBE MD

Endocrinology, Diabetes Metabolism

3,263

$516K

268
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 47%

$158
Average prescription price

Avg: $159

BARRRY LANCE M.D.

Endocrinology, Diabetes Metabolism

3,149

$420K

206
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 47%

$133
Average prescription price

Avg: $159

JAMES DICKE M.D.

Endocrinology, Diabetes Metabolism

3,127

$650K

285
225 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 47%

$208
Average prescription price

Avg: $159

CRISTIAN VILCU M.D.

Endocrinology, Diabetes Metabolism

2,821

$535K

296
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 47%

$190
Average prescription price

Avg: $159

KENNETH PATRICK LIGARAY M.D.

Endocrinology, Diabetes Metabolism

2,729

$604K

301
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 47%

$221
Average prescription price

Avg: $159

JULIE DUCHARME MD

Endocrinology, Diabetes Metabolism

2,653

$550K

244
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 47%

$207
Average prescription price

Avg: $159

THOMAS POZEFSKY M.D.

Endocrinology, Diabetes Metabolism

2,498

$205K

193
184 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 47%

$82
Average prescription price

Avg: $159

OSVALDO GONZALEZ M.D.

Endocrinology, Diabetes Metabolism

2,430

$396K

321
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 47%

$163
Average prescription price

Avg: $159

VISHAL DATTA M.D.

Endocrinology, Diabetes Metabolism

2,319

$566K

347
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 47%

$244
Average prescription price

Avg: $159

AJAY DASHOTTAR M.D.

Endocrinology, Diabetes Metabolism

2,301

$240K

163
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 47%

$104
Average prescription price

Avg: $159

JOHN MERENDINO M.D.

Endocrinology, Diabetes Metabolism

2,220

$230K

192
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 47%

$104
Average prescription price

Avg: $159

JEAN PARK M.D.

Endocrinology, Diabetes Metabolism

2,192

$466K

299
191 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 47%

$212
Average prescription price

Avg: $159

MADHU KATIKINENI M.D.

Endocrinology, Diabetes Metabolism

2,122

$226K

161
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 47%

$107
Average prescription price

Avg: $159

PAUL SACK M.D.

Endocrinology, Diabetes Metabolism

2,080

$366K

226
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 47%

$176
Average prescription price

Avg: $159

NICHOLAS ARGENTO M.D.L

Endocrinology, Diabetes Metabolism

2,073

$405K

174
145 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 47%

$195
Average prescription price

Avg: $159

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank